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ABSTRACT 
Hippocampal lesions tend to facilitate two way active avoidance (2WAA) conditioning, 
where rats learn to cross to the opposite side of a conditioning chamber to avoid a 
tone-signaled foot shock. This classical finding has been suggested to reflect that 
hippocampus-dependent place/context memory inhibits 2WAA (a crossing response to the 
opposite side is inhibited by the memory that this is the place where a shock was received on 
the previous trial). However, more recent research suggests other aspects of hippocampal 
function that may support 2WAA learning. More specifically, the ventral hippocampus has 
been shown to contribute to behavioral responses to aversive stimuli and to positively 
modulate the meso-accumbens dopamine system, whose activation has been implicated in 
2WAA learning. Permanent hippocampal lesions may not reveal these contributions because, 
following complete and permanent loss of hippocampal output, other brain regions may 
mediate these processes or because deficits could be masked by lesion-induced 
extra-hippocampal changes, including an upregulation of accumbal dopamine transmission. 
Here, we re-examined the hippocampal role in 2WAA learning in Wistar rats, using 
permanent NMDA-induced neurotoxic lesions and temporary functional inhibition by 
muscimol or tetrodotoxin (TTX) infusion. Complete hippocampal lesions tended to facilitate 
2WAA learning, whereas ventral or dorsal hippocampal lesions had no effect. In contrast, 
ventral or dorsal hippocampal muscimol or TTX infusions impaired 2WAA learning. Ventral 
infusions caused an immediate impairment, whereas after dorsal infusions rats showed intact 
2WAA learning for 40-50 min, before a marked deficit emerged. These data show that 
functional inhibition of ventral hippocampus disrupts 2WAA learning, while the delayed 
impairment following dorsal infusions may reflect the time required for drug diffusion to 
ventral hippocampus. Overall, using temporary functional inhibition, our study shows that the 
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ventral hippocampus contributes to 2WAA learning. Permanent lesions may not reveal these 
contributions due to functional compensation and extra-hippocampal lesion effects. 
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INTRODUCTION 
A classical finding from hippocampal lesion studies is that damage to the hippocampal 
system facilitates two way active avoidance (2WAA) conditioning in rats (Gray and 
McNaughton, 1983; Guillazo-Blanch et al., 2002; O'Keefe and Nadel, 1978; Olton and 
Isaacson, 1968; Pouzet et al., 1999; Weiner et al., 1998; Tonkiss et al., 1990). In 2WAA 
conditioning, rats are trained to avoid a foot shock by crossing to the opposite side of a 
conditioning chamber in response to a conditioned stimulus (CS) predicting the foot shock. 
Facilitation of 2WAA conditioning by hippocampal damage has been suggested to reflect the 
disruption of place or contextual memory, a well-established consequence of hippocampal 
lesions (Anagnostaras et al., 2001; Bannerman et al., 2004; Bast, 2007; Bast et al., 2009; 
Morris et al., 1980; Morris et al., 1990; Nadel and Hardt, 2004; O'Keefe and Nadel, 1978; 
Rudy, 2009). More specifically, it was proposed that 2WAA requires the rat to overcome fear 
of a place or context to return to an area of the conditioning chamber where it has just 
received a foot shock. Hippocampal damage, disrupting place or context memory, might 
reduce such fear and thereby facilitate 2WAA (Guillazo-Blanch et al., 2002;  O'Keefe and 
Nadel,  1978;  Olton and Isaacson, 1968). Indeed, hippocampal lesions especially disrupt 
the rapid, one-trial, place and contextual learning required to remember the place or context of 
events, such as a shock, experienced on a specific trial (Bast et al., 2009; Morris et al., 1990; 
Wiltgen et al., 2006). 
However, while hippocampus-dependent one-trial place or context memory may 
inhibit 2WAA, other aspects of hippocampal function might be expected to support such 
behavior. First, the hippocampus, especially the ventral part, supports behavioral responses 
and fear conditioning to aversive stimuli in a variety of paradigms (Bannerman et al., 2004; 
Bast et al., 2001a, Bast et al., 2001b, Bast, 2007; Bast, 2011; Fanselow and Dong, 2010; 
Kjelstrup et al., 2002; Pentkowski et al., 2006). Second, activity of the hippocampus, 
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especially the ventral part, positively modulates midbrain dopamine projections to the 
forebrain, including nucleus accumbens (Bast, 2007; Bast, 2011; Grace et al., 2007; 
Taepavarapruk et al., 2008), and stimulation of midbrain dopamine projections and 
accumbens dopamine transmission have been implicated in the facilitation of 2WAA 
conditioning (Darvas et al., 2011; Ilango et al., 2012; Shumake et al., 2010; Wadenberg and 
Hicks, 1999; Boschen et al. 2011; Smith et al., 2007; Dombrowski et al., 2013;). 
Hippocampal lesions may fail to reveal such hippocampal contributions to 2WAA 
conditioning due to functional compensation and secondary changes in other brain regions. 
First, other brain structures implicated in aversively motivated responses (Maren and Quirk, 
2004) or in the modulation of the meso-accumbens dopamine system (Sesack and Grace, 
2010) may compensate for the permanent loss of hippocampal contributions. Second, there is 
evidence that hippocampal lesions result in secondary changes in the nucleus accumbens that 
facilitate local dopamine transmission, including dopamine receptor hypersensitivity 
(Mittleman et al., 1993) and enhanced dopamine transmission (Lipska et al., 1992; Wilkinson 
et al., 1993). 
Compared to permanent hippocampal lesions, temporary functional inactivation of the 
hippocampus may afford less opportunity for compensatory adaptations and cause less 
secondary changes in efferent sites (Lomber, 1999). Therefore, temporary inactivation may 
reveal some aspects of hippocampal function that have eluded lesion studies. In support of 
this possibility, we have successfully used functional inactivation to reveal a previously 
undiscovered hippocampal role in certain sensorimotor processes (consistent with functional 
links to prefrontal and subcortical sites involved in these processes). More specifically, 
temporary hippocampal inactivation by the GABA-A receptor agonist muscimol or the 
sodium channel blocker tetrodotoxin (TTX) reduces both locomotor activity and prepulse 
inhibition, whereas hippocampal lesions do either not affect or, in the case of locomotor 
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activity, even tend to increase these measures (Bast and Feldon, 2003; Bast et al., 2001b; 
Zhang et al., 2002). 
In the present study, we examined the contribution of the hippocampus to 2WAA 
conditioning in rats, using temporary functional inactivation by bilateral infusions of the 
GABA-A receptor agonist muscimol or the sodium channel blocker TTX into the dorsal or 
ventral hippocampus. For comparison, we also examined the effect of NMDA-induced 
neurotoxic lesions to the dorsal, ventral or complete hippocampus. We predicted that 
temporary hippocampal inactivation, especially if targeting the ventral part, would impair 
2WAA conditioning, whereas hippocampal lesions would, if at all, facilitate conditioning. 
 
MATERIALS AND METHODS 
Subjects 
 The subjects were 108 male Wistar rats (Zur:WIST[HanIbm], Research Unit 
Schwerzenbach, Schwerzenbach, Switzerland), weighing about 250 g and aged 2 to 2.5 
months at the time of surgery. Forty-seven rats were used for the lesion experiment and 61 
rats for the infusion experiments. Rats were housed in groups of four per cage under a 
reversed light-dark cycle (lights on: 19:00-07:00) in a temperature (21 ± 1°C) and humidity 
(55 ± 5%) controlled room. All rats were allowed free access to food and water. After surgery, 
they were caged individually. Starting one day before surgery and then throughout the studies, 
all rats were handled daily. Behavioral testing was carried out in the dark phase of the cycle. 
All experiments were conducted in accordance with the principles of laboratory animal care 
(NIH publication no. 86-23, revised 1985) and Swiss regulations for animal experimentation.  
 
Stereotaxic surgery 
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 Rats were anesthetized with Nembutal (sodium pentobarbital, 50 mg/ml, Abbott Labs, 
North Chicago, IL) at a dose of 1 ml/kg (i.p.) and their head was placed in a Kopf stereotaxic 
frame. After application of a local anesthetic (lidocaine), an incision was made on the scalp 
and the skull surface exposed. Bregma and lambda were aligned in the same horizontal plane. 
 
Hippocampal neurotoxic lesion 
 Forty-seven rats were allocated to four groups: 10 rats received bilateral lesions of the 
dorsal hippocampus, 10 received bilateral lesions of the ventral hippocampus, 10 received 
bilateral lesions of the complete hippocampus, 8 rats receiving sham surgery and 9 unoperated 
rats served as controls. For each of the lesion groups, the smallest possible craniotomy was 
made above the injection sites on each side of the brain. The procedure used to make the 
lesions was the same as described in Zhang et al (2004). Rats received multiple injections of 
N-methyl-D-aspartate (NMDA, in volumes between 0.025 and 0.10 µl per injection) 
dissolved in 0.1M phosphate-buffered saline (PBS, pH 7.4) at a concentration of 10 mg/ml. 
Rats in the complete hippocampal lesion group received injections at 36 sites, rats in the 
dorsal hippocampal lesion group at 22 sites and rats in the ventral hippocampal lesion group 
at 14 sites (Table 1). The injection cannula was left in place at each injection site for 60 s 
before being retracted. Rats in the sham surgery group were placed in the frame, had the skull 
exposed and were given microinjections of PBS, as a vehicle control (four rats received PBS 
injections at the 22 sites used in the dorsal hippocampal lesion group and the other four at the 
14 sites used in the ventral hippocampal lesion group). The scalps were then stitched. After 
surgery, all rats were allowed at least 2 weeks to recover before the beginning of the 2WAA 
experiment. 
 
              --------------------------- 
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                             Table 1 
                      --------------------------- 
 
Implantation of guide cannulae for intrahippocampal infusions 
Sixty-one rats were used for the hippocampal infusion experiments. Rats were placed in 
the stereotaxic frame and a small hole (1.5 mm in diameter) was drilled on each side of the 
skull to reveal the cortex overlying the hippocampus. Stainless steel guide cannulae (26 gauge, 
9 mm or 7 mm for ventral or dorsal hippocampus, respectively) in a Perspex holder (custom 
made) were implanted bilaterally into the brain aiming at the ventral (-5.2 mm posterior and 
±5.0 mm lateral to bregma, and -5.0 mm ventral to dura) or dorsal (-3.0 mm posterior and 
±1.5 mm lateral to bregma, and -2.5 mm ventral to dura) hippocampus, using the same 
coordinates as in previous studies (Bast and Feldon, 2003; Bast et al, 2001b; Zhang et al, 
2002; Zhang et al., 2014). The guide cannulae were fixed to the skull with three anchoring 
skull screws and dental cement. Stainless steel stylets (34 gauge) extending 0.5 mm beyond 
the tips of the guide cannulae were placed inside the guide cannulae to prevent occlusion. 
After surgery, rats were allowed to recover for five days before the beginning of the 2WAA 
experiments. During this time, the experimenter conducted daily health checks, gently 
habituated the rats to the handling required for the infusions, and replaced any missing stylet. 
 
Intracerebral infusions  
   The rats were manually restrained, the stylets removed carefully, and infusion cannulae 
(34 gauge, stainless steel) were inserted into the brain through the previously implanted guide 
cannulae. The tips of the infusion cannulae protruded 1.5 mm beyond the tip of the guide 
cannulae into the ventral or dorsal hippocampus, resulting in final dorso-ventral coordinates 
of 6.5 and 4.0 mm below dura in the ventral and dorsal hippocampus, respectively, as in our 
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previous studies (Bast and Feldon, 2003; Bast et al, 2001b; Zhang et al., 2002; Zhang et al., 
2014). The infusion cannulae were connected to 10-µl Hamilton microsyringes by flexible 
PEEK tubing. The syringes were mounted on a Kds microinfusion pump. All rats were 
infused bilaterally and the infusion volume was 0.5 µl/side, delivered at the rate of 0.5 µl/min. 
Afterwards, the infusion cannulae were kept in place for an additional 60 s to allow for tissue 
absorption of the infusion bolus before being replaced by the stylets. As in our previous 
studies (Bast et al., 2001b, Zhang et al., 2002), muscimol (1 µg/0.5 µl/side) was infused 
immediately and TTX (10 ng/0.5 ml/side) 20 min before behavioral testing. Accordingly, half 
of the rats infused with vehicle, i.e. 0.9% saline (0.5 µl/side), received infusion immediately 
before the behavioral sessions, the other half 20 min before the behavioral sessions.  
 
Drugs 
 Muscimol [C4H6N2O2(1/2 H2O); Tocris, Bristol, UK] was dissolved in 0.9% saline at a 
concentration of 2 µg/µl on the day of infusion. TTX (C11H17N3O8; Tocris, Bristol, UK) was 
stored at –40°C in aliquots containing 40 ng/µl in 0.9% saline. On the day of infusion, these 
aliquots were thawed and diluted with 0.9% saline to obtain a solution with a concentration of 
20 ng/µl for intra-hippocampal infusion. 
 
Two-way active avoidance paradigm 
Apparatus 
     The apparatus consisted of four identical 2-way shuttle boxes (Coulbourn Instruments, 
model E10-16TC), each set in a ventilated, sound- and light-attenuating shell (model E10-20). 
The internal dimensions of each chamber were 35 x 17 x 21.5 cm as measured from the raised 
grid floor. The box was divided by an aluminium hurdle (17 cm long, 4 cm high) into two 
identical compartments. The hurdle was low enough to allow the subject to shuttle freely 
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between the two compartments and thin enough to ensure that the rats could not stand on it to 
avoid foot shocks. The modular shock floor (model E10-16RF) consisted of 24 stainless steel 
rods 0.48 cm in diameter and spaced 1.5 cm apart, center to center. The grid floor was hinged 
in the middle of the box and thus displacement of the subject from one compartment to the 
other (i.e., a shuttle) could be detected by the corresponding pivoting of the gird floor unit. 
Scrambled shocks could be delivered from a constant direct current shock generator (CI, 
model E13-14) and scanner (model E13-13) set at 0.5 mA. The chamber was illuminated 
during the whole experimental session by two small light bulbs (1.8W, houselights), mounted 
19 cm above the grid floor in the middle of the side walls. The CS was an 85-dB tone 
produced by a 2.9 kHz tone module (model E12-02) placed behind the shuttle box on the 
floor of the isolation cubicle. Background noise was provided by a ventilation fan affixed to 
each isolation cubicle. Data acquisition and stimulus parameters were controlled by a Compaq 
PC computer using a DOS-based software program developed in our laboratory. 
 
Procedures 
     Two-way active avoidance procedures were based on previous studies (Pouzet et al., 
1999; Weiner et al., 1998). Testing was carried out over 4 days, with habituation to the test 
apparatus on day 1, 2WAA acquisition on day 2 and a session to test retention of the learned 
avoidance response on day 4. Individual rats completed all stages of the experiment in the 
same shuttle box. 
     Habituation to the apparatus: Rats were placed in the shuttle box with the house lights 
on for 60 min and then returned to their home cage. The number of spontaneous crosses 
between the two sides of the shuttle box was recorded during the habituation session, 
providing a measure of basal activity. Rats in the intracerebral infusion study were 
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subsequently matched for this measure of activity prior to their assignment to one of the three 
drug infusion groups.  
     Acquisition of two way active avoidance: Acquisition training was carried out one day 
after the habituation session. In the infusion experiments, the infusions were conducted before 
acquisition training. Each animal was placed into the experimental chamber and received 100 
avoidance trials, presented on a variable inter-trial interval (ITI), ranging from 10 to 90 s 
(average 50 s). Each avoidance trial began with the onset of a 10 s tone CS. If the animal did 
not shuttle to the opposite compartment during the 10 s tone (avoidance response), a foot 
shock (unconditioned stimulus, US) of 0.5 mA was delivered, the tone remaining on with the 
shock. The maximal duration of the shock was 2 s. A shuttle response during this period 
(escape response) terminated the shock as well as the CS. If the animal did not cross during 
the entire 12 s tone-shock trial, the response was recorded as an escape failure. Shuttle 
response latency was calculated as a combined avoidance / escape latency throughout the 
100-trial test session, such that a value of 0-12 seconds was assigned to each animal 
regardless of whether an animal avoided (0-10 s), escaped (10-12 s) or did not escape the 
shock (maximal 12 s).  
      Test of two way active avoidance retention: Two days after the initial acquisition 
training, all of the rats were subjected to a retention test of 2WAA. The procedure was the 
same as used in acquisition training. Avoidance responses and the latencies were recorded as 
in the acquisition training. The aim of this test was to assess the retention of the 2WAA 
response learnt two days earlier, as well as the possible long-term effects of the infusion. 
Measures of two way active avoidance and other behavioral measures: As measures 
of 2WAA, the number of avoidance responses and response latencies were recorded in 10 trial 
blocks. As a control measure for potential non-specific motor effects, crossings during the ITI 
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were also recorded in 10 trial blocks. In addition, the overall number of escape failures across 
the 100 trial sessions was recorded. 
  
Experimental design 
Rats were tested in batches of 4. The different testing boxes and the order of testing 
were counterbalanced among the experimental groups as far as possible. 
 
Lesion experiment (Experiment 1) 
There were four groups: bilateral dorsal hippocampal lesion group (n=10), bilateral 
ventral hippocampal lesion group (n=10), bilateral complete hippocampal lesion group (n=10) 
and control group, consisting of sham (n=8) operated and unoperated (n=9) rats ( overall 
n=17). Before combining sham operated and unoperated rats into one control group, separate 
analysis confirmed that these two groups did not differ in any of the behavioral measures 
examined (all F < 0.68). 
 
Infusion experiments (Experiments 2 and 3) 
Rats with bilateral implantation of guide cannulae targeting ventral (n = 17) or dorsal 
hippocampus (n = 44) were used to test the effects of ventral (Experiment 2) or dorsal 
hippocampal infusions (Experiment 3). Infusions were only made before the acquisition 
session. Based on matched activity measures during the habituation session, the cannulated 
rats were allocated to one of three infusion groups to receive bilateral infusion of 0.5 µl 
saline/side, 10 ng TTX/0.5µl/side, or 1 µg muscimol/0.5 µl/side  into either the ventral or the 
dorsal hippocampus. In the experiment involving ventral hippocampal infusions, group sizes 
were: saline, n=6; TTX, n=4; muscimol, n=7. In the experiments involving dorsal 
hippocampal infusions, group sizes were: saline, n=14; TTX, n=15; muscimol, n=15. 
Page 12 of 44
John Wiley & Sons
Hippocampus
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 13
     
Histology 
   After the completion of behavioral testing, all hippocampal lesioned, cannulated and 
five randomly selected sham-operated rats were deeply anesthetized with an overdose of 2.5 
ml/kg Nembutal (sodium pentobarbital, 50 mg/ml, i.p.) and transcardially perfused with 0.9% 
NaCl solution, followed by 120 ml of 4% formol saline (4°C) to fix the brain tissue. The 
brains were extracted from the skull, post-fixed in 4% formalin solution, and subsequently cut 
into 40-µm coronal sections on a freezing microtome. For the examination of the hippocampal 
lesions or the injection sites, every fourth section through the hippocampus was mounted onto 
gelatine coated slides and stained with cresyl violet. After staining, the sections were 
dehydrated through an alcohol series, cleared with xylene, and coverslipped with Eukitt 
(Kindler, Freiburg, Germany). Subsequently, the sections were examined with a light 
microscope to verify lesions and cannula placements. Lesions were quantified as outlined 
below and infusion sites were mapped onto plates taken from the atlas of Paxinos and Watson 
(1998).  
 
Quantification of lesion size  
Hippocampal lesion size was measured using a method adapted from Bast et al. (2009). 
Briefly, for each rat from the lesion and sham groups, the relative volume of intact/spared 
hippocampal tissue was measured. The intact hippocampus (including CA1, CA3, and dentate 
gyrus) in each coronal section was outlined using the light microscope connected via a digital 
camera to a computer running ImageJ software (version 1.7, National Institutes of Health, 
Maryland). The total hippocampal area was measured in pixels for each brain and the mean 
hippocampal area in pixels was calculated for each group. The proportion of spared tissue in 
individual brains from the lesion group was calculated by dividing the spared hippocampal 
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area by the mean hippocampal area in the sham group, and the extent of hippocampal damage 
of each subject for each group was calculated as 100% minus percentage of spared tissue. 
From these values, the mean % of hippocampal damage was calculated for each lesion group.  
 
Data analysis 
Statistical analyses were performed with StatView software (Abacus Concepts, Inc., 
Berkeley, CA, 1992). Groups were used as between-subjects factor and blocks of 10 trials as 
repeated measures. Post hoc comparisons were conducted using Fisher's protected least 
significant difference test. Significant differences were accepted at P < 0.05. Values are 
presented as means. In the text, variability is indicated by the standard error of the mean 
(S.E.M.). In the figures, for the sake of clarity, the standard error (S.E.) derived from the 
appropriate mean square of the ANOVA indicates variability.  
 
 
RESULTS 
 
Histology 
Experiment 1: Neurotoxic hippocampal lesions 
Photomicrographs of coronal sections taken from representative rats with bilateral 
dorsal, ventral and complete hippocampal excitotoxic lesions together with schematic 
reconstructions of the minimal (solid areas) and maximal (solid and shaded areas) damage are 
depicted in Fig. 1A. Sham lesioned rats showed no discernable damage to the hippocampus or 
to extra-hippocampal areas, apart from occasional small traces of the needle tracks. 
Rats with lesions targeting the dorsal hippocampus showed substantial cell loss and 
extensive gliosis in the dorsal half to two-thirds of the hippocampus (including the dentate 
gyrus, CA1 and CA3), while the ventral third was intact. In the most anterior part of the 
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dorsal hippocampus, minor sparing was seen in the medial dentate gyrus and CA1 subfield. 
The mean amount of damage ± SEM was 58.5 ± 2.4% of total hippocampal volume (range: 
49.8 - 67.2%). In addition to the intended hippocampal damage, there was some damage to 
the dorsal subiculum and to the cortex overlying the hippocampus. Rats with lesions targeting 
the ventral hippocampus typically showed extensive cell loss and gliosis in the ventral half to 
two thirds of the hippocampus, while the dorsal third remained intact. In some cases, minor 
damage was seen in the ventral subiculum and the ventral pre- and parasubiculum; however, 
this damage never extended into the entorhinal cortex. In three of the ventral lesioned rats, 
only very limited damage could be discerned in the ventral hippocampus (less than 10% of 
total hippocampal volume), and these three rats were therefore excluded from further analysis. 
The mean amount of hippocampal damage in the rest of the ventral hippocampal lesion group 
was 55.8 ± 4.1% of total hippocampal volume (range: 38.0 - 72.6%).  
The complete hippocampal lesion group was characterized by substantial cell loss and 
intense gliosis throughout the entire longitudinal extent of the hippocampus. In some cases, 
minor sparing of the most caudo-medial part of the dorsal hippocampus (dentate gyrus and 
CA1) was observed, while in other cases sparing of the dentate gyrus granule cells at the most 
ventral tip of the hippocampus was observed. No signs of damage to the amygdala, or dorsal 
thalamus were noted. In some cases, some damage to the ventral and dorsal subiculum and the 
ventral and dorsal pre- and parasubiculum was observed, yet this damage did not extend into 
the entorhinal cortex. In general, the damage present in the complete hippocampal lesion 
group was comparable to the extent and location of the damage seen in the dorsal and ventral 
hippocampal lesion groups separately. One complete hippocampal lesioned rat showed very 
limited damage (less than 10% of total hippocampal volume), and consequently this rat was 
excluded from further analysis. The mean amount of hippocampal damage in the rest of the 
complete hippocampal lesion group was 100 ± 3.6% of the total hippocampal volume (range: 
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84.4 – 116.7%). The final number of rats used in the behavioural analysis was 17 Cont (9 
unoperated, 8 sham-lesioned), 10 DH, 7 VH and 9 CH. 
 
Experiments 2 and 3: Hippocampal infusion sites  
In all 61 cannulated rats, the centers of the infusion sites, i.e. the tips of the infusion 
cannulae, were located within or around the border of the ventral (n = 17, Experiment 2) or 
dorsal (n = 44, Experiment 3) hippocampus as intended (Fig. 1B). Tissue damage was found 
in the hippocampus and the cortex overlying the hippocampus. This damage was restricted to 
the area immediately surrounding the guide and infusion cannulae.  
          ______________________ 
            Fig 1 insert about here 
           ______________________ 
 
Experiment 1: Dorsal or ventral hippocampal lesions do not affect two-way active 
avoidance conditioning, whereas complete hippocampal lesions tend to improve 
performance  
 Dorsal or ventral hippocampal lesions did not alter conditioned 2WAA acquisition, 
while complete hippocampal lesions tended to enhance acquisition; this was supported by the 
analysis of avoidance responses (Fig. 2A, left panel) and of the latencies to avoid or escape 
the foot shook following CS onset (Fig. 2B, left panel). The analysis of percent avoidance 
response during acquisition test using a 4 x 10 (group x blocks of 10 trials) ANOVA only 
yielded a significant main effect of blocks (F9, 351 = 46.4, P < 0.0001), indicating an overall 
increase in avoidance response as a function of training. Neither the main effect of group (F3, 
39 = 1.36, P > 0.26) nor the group x blocks interaction (F27, 351 = 1.12, P > 0.31) was 
significant. However, consistent with previous evidence for improved acquisition of 2WAA 
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behavior following substantial damage to the hippocampus or fimbria fornix (see 
Introduction), rats with complete hippocampal lesions tended to show more avoidance 
responses as compared to the other groups during the first half (50 trials) of the acquisition 
session. Indeed, a separate 4 x 5 (group x blocks of 10 trials) ANOVA of the percent 
avoidance responses during the first 50 trials of the acquisition test yielded a strong trend 
towards a main effect of group (F3, 39 = 2.57, P = 0.06). Post hoc comparisons revealed that 
the average percentage of avoidance responses across the first 50 trials was increased in the 
complete hippocampal lesion group (58.0 ± 8.6%) as compared to the control (33.5 ± 5.6%, P 
< 0.02) and dorsal hippocampal lesion group (33.6 ± 6.8%, P < 0.03). There was no 
significant difference between the complete and the ventral lesion (44.8 ± 8.6%) groups (P > 
0.26) and between the control, dorsal and ventral groups (all P’s > 0.28). Analysis of the 
response latencies yielded similar results. A 4 x 10 (group x blocks of 10-trials) ANOVA of 
response latencies during acquisition training revealed only a significant main effect of blocks 
(F9, 351 = 42.2, P < 0.0001), indicating an overall decrease of response latencies as a function 
of blocks, but neither the main effect of group (F3, 39 = 2.02, P > 0.12) nor the group x 
blocks interaction (F27, 351 = 1.06, P > 0.38) attained significance. However, rats with 
complete hippocampal lesions exhibited shorter response latencies than the three other groups 
during the first 50 trials of acquisition training. A separate 4 x 5 (group x blocks of 10-trials) 
ANOVA of the crossing response latency during the first 50 trials revealed a significant main 
effect of group (F3, 39 = 3.31, P < 0.03), alongside a highly significant main effect of blocks 
(F4, 156 = 61.4, P < 0.0001) with no interaction group X block (F12, 156 = 1.23, P > 0.26). 
Post hoc comparisons revealed that the average response latencies of the complete 
hippocampal lesion group (6.2 ± 0.8 s) across the first 50 trials were significantly shorter than 
those of the control (8.5 ± 0.4 s, P < 0.01) and dorsal hippocampal lesion group (8.6 ± 0.6 s, P 
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< 0.01). There were no significant differences between complete and ventral lesion (7.6 ± 0.7 
s) group (P> 0.15) and between control, dorsal and ventral group (all Ps > 0.32). 
Two days after acquisition training, all groups showed similar 2WAA behavior during 
the retention test in terms of avoidance responses (Fig. 2A, right panel). However, the control 
group tended to show slightly higher response latencies, especially as compared to the 
complete hippocampal lesion group, during the beginning of the retention session (Fig. 2B, 
right panel). A 4 x 10 (group x blocks of 10 trials) ANOVA of avoidance responses yielded 
only a significant main effect of blocks (F9, 351 = 20.3, P < 0.0001), reflecting an 
improvement in 2WAA responding during the first 20-30 trials. Neither the main effect of 
group (F3, 39 = 1.03, P > 0.39) nor the group x blocks interaction (F27, 351 = 1.05, P > 0.39) 
were significant. A 4 x 10 (group x blocks of 10 trials) ANOVA of response latencies during 
retention test yielded a significant main effect of blocks (F9, 351 = 11.8, P < 0.0001), no main 
effect of group (F3, 39 = 0.58, P > 0.6), but a strong trend towards an interaction of group x 
blocks (F27, 351 = 1.46, P = 0.069). This trend reflected lower latencies in the lesion groups, 
especially in the complete hippocampal lesion group, as compared to the control group during 
the first 20 trials, before asymptotic values were reached by all groups. The latency data 
indicate that the complete hippocampal lesion group carried over some of the facilitated 
2WAA performance from the acquisition to the retention test session. 
           ______________________ 
             Fig 2 insert about here 
            ______________________ 
 
Experiment 2: Tetrodotoxin or muscimol infusion into the ventral hippocampus disrupt 
the acquisition of two-way active avoidance behavior 
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Tetrodotoxin and muscimol infusion into the ventral hippocampus markedly disrupted 
acquisition of 2WAA behavior, with avoidance responses remaining at a very low level (Fig. 
3A, left panel) and response latencies remaining high (Fig. 3B, left panel) throughout the 
whole acquisition session. A 3 x 10 (group x blocks of 10 trials) ANOVA of the percent 
avoidance response during acquisition test yielded highly significant main effects of group 
(F2, 14 = 14.23, P < 0.0005) and of blocks (F9, 126 = 10.65, P < 0.0001) and a highly 
significant interaction of group x blocks (F18, 126 = 6.03, P < 0.0001). The significant 
interaction group x blocks of 10 trials reflected that the number of avoidance responses in the 
saline group increased as training progressed, whereas the TTX and muscimol rats showed 
very low levels of avoidance responses throughout the acquisition session. Analysis of 
response latencies produced similar results. An overall 3 x 10 (groups x blocks of 10-trials) 
ANOVA of response latencies during acquisition training showed a significant main effect of 
group (F2, 14 = 9.70, P < 0.003) and of blocks (F9, 126 = 9.14, P < 0.0001), as well as a 
significant group x blocks interaction (F18, 126 = 6.68, P < 0.0001). The significant 
interaction of group x blocks of 10-trials reflected that response latencies in the saline group 
decreased as a function of acquisition training, whereas latencies remained high in the TTX 
and muscimol groups. 
   Two days after acquisition training, the retention test was carried out without infusion 
(Fig. 3A and B, right panels). Rats that had received TTX or muscimol into the ventral 
hippocampus before acquisition training still showed evidence for slightly impaired 2WAA 
behavior, probably reflecting that, in contrast to the saline group, they benefited only little 
from the preceding acquisition training. However, all three groups showed a similar increase 
in avoidance response as the session progressed, suggesting that the impairment in 2WAA 
acquisition induced by TTX or muscimol infusion was temporary and reversible. A 3 x 10 
(group x blocks of 10 trials) ANOVA of percent avoidance response during retention test 
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revealed a strong trend towards a main effect of group (F2, 14 = 3.5, P = 0.059) and a main 
effect of blocks (F9, 126 = 23.28, P < 0.0001), but no interaction group x block (F18, 126 = 
1.53, P = 0.92). Pairwise comparisons between groups revealed that the overall percentage of 
avoidance responses during the retention test was higher in the saline group (88.83 ± 0.40%) 
than in the muscimol (65.71 ± 4.9%, P < 0.03) and TTX (69.00 ± 15.27%, P = 0.08) groups, 
which did not differ from each other (P = 0.75). Analysis of response latencies using a 3 x 10 
(groups x blocks of 10 trials) ANOVA only yielded a main effect of blocks (F9, 126 = 14.75, 
P < 0.0001), without a main effect of groups (F2, 14 = 2.15, P > 0.15) or an interaction of 
groups x blocks (F18, 126 = 1.21, P > 0.26), even though numerically latencies were higher in 
the muscimol and TTX groups compared to the saline group. 
          ______________________ 
            Fig 3 insert about here 
           ______________________ 
 
Experiment 3: Tetrodotoxin or muscimol infusion into the dorsal hippocampus cause a 
delayed disruption in the acquisition of two-way active avoidance behavior  
TTX and muscimol infusions into the dorsal hippocampus disrupted 2WAA acquisition, 
as indicated by reduced avoidance responses (Fig. 4A, left panel) and increased response 
latencies (Fig. 4B, right panel). Interestingly, the deficit only emerged during the last 40-50 
trials of acquisition training. A 3 x 10 (group x blocks of 10 trials) ANOVA of the percent 
avoidance response during acquisition training revealed a strong trend towards a main effect 
of group (F2, 41 = 2.95, P = 0.06), a main effect of blocks (F9, 369 = 30.68, P < 0.0001), as 
well as a highly significant group x blocks interaction (F18, 369 = 4.12, P < 0.0001). The 
significant interaction of group x block of 10-trials reflected that the reduction of avoidance 
responses in the TTX and muscimol groups as compared to the saline group emerged during 
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the second half of acquisition training. Similarly, a 3 x 10 (groups x blocks of 10-trials) 
ANOVA of response latencies during acquisition training yielded a significant main effect of 
group (F2, 41 = 4.0, P < 0.03), a highly significant main effect of blocks (F9, 369 = 28.2, P < 
0.0001) and a significant groups x blocks interaction (F18, 369 = 5.73, P < 0.0001). The 
significant interaction of groups x blocks of 10-trials reflected that the increase of response 
latencies in the TTX and muscimol groups in comparison to the saline group emerged during 
the second half of acquisition training. Two days after acquisition training, when tested in the 
absence of infusion, the TTX and muscimol groups still showed impaired 2WAA behavior as 
compared to the saline group during the first half of the retention session, but had acquired 
similar performance levels by the beginning of the second half (Fig. 4A and B, right panels). 
A 3 x 10 (group x blocks of 10 trials) ANOVA of percent avoidance responses yielded a 
significant main effect of blocks (F9, 369 = 38.6, P < 0.0001) and a significant groups x 
blocks interaction (F18, 369 = 3.10, P < 0.001), but no main effect of group (F2, 41 = 1.47, 
P > 0.24). The interaction of groups x blocks reflected that the saline group reached 
asymptotic levels of active avoidance responses within the first block of 10 trials, whereas  
the TTX and muscimol groups only showed such high levels of avoidance responses during 
the second half of the session. Analysis of response latencies yielded similar results. A 3 x 10 
(groups x blocks of 10 trials) ANOVA of response latencies during the retention test yielded a 
significant main effect of blocks (F9, 369 = 27.5, P < 0.0001) and a significant groups x 
blocks interaction (F18, 369 = 3.12, P < 0.0001), but no main effect of groups (F2, 41 = 1.72, 
P > 0.19). The significant groups x blocks interaction reflected that the saline rats reached 
asymptotically low levels of response latencies within the first block of 10 trials, whereas the 
TTX and muscimol rats showed similarly low latencies only during the second half of the 
retention test.  
         ______________________ 
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           Fig 4 insert about here 
          ______________________ 
 
Experiments 1-3: Changes in ITI crossings or escape failures cannot account for the 
effects of hippocampal lesions or inactivation on measures of two way active avoidance 
learning 
Changes in ITI crossings are often used to assess changes in motor activity that may 
account for improved or impaired 2WAA learning (Boschen et al., 2011; Darvas et al., 2011; 
Guillazo-Blanch et al., 2002; Shumake et al., 2010; Vinader-Caerols et al., 1996). The pattern 
of ITI crossings during acquisition and retention session of Experiments 1 to 3 (Fig. 5 left) 
does not support that group differences in motor activity, as reflected by ITI crossings, can 
account for the group differences in 2WAA learning (Figs 2-4). In Experiment 1, ITI 
crossings during acquisition did not clearly differ between lesion groups (main effect of group: 
F3,39 = 1.74, P = 0.17; interaction group x block of 10 trials: F27,351 < 1); during retention, 
there was an interaction between group and block of 10 trials (F27,351 = 1,69, P = 0.019), 
mainly reflecting that complete and ventral hippocampal lesion groups showed less ITI 
crossings, as compared to the other groups, during blocks 3 to 5. While these differences are 
not easy to explain and might reflect a chance finding, any differences in ITI crossings during 
retention can clearly not account for the differences in 2WAA learning observed during 
acquisition. In Experiment 2, there was a strong trend toward an interaction of ventral 
hippocampal infusion group with block of 10 trials during acquisition (F18,126 = 1.62, P = 
0.06), reflecting that the saline group tended to show the highest number of ITI crossings 
during block 1, 3, 9 and 10, whereas, during block 2, the saline group showed the lowest 
number of crossings and, during the remaining blocks, TTX infused rats tended to show the 
highest number of crossings, with the muscimol group tending to show the lowest levels. 
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Again these differences were likely due to chance and it is difficult to see how they could 
account for the reduced 2WAA learning in the muscimol and TTX groups. During retention, 
numbers of ITI crossings were lower in the group receiving muscimol into the ventral 
hippocampus, as compared to the saline and TTX groups (F 2,14 = 4.11, P = 0.04; interaction 
group X block of 10 trial: F < 1), even though only the difference between muscimol and 
saline was significant (P = 0.012, two other Ps > 0.17). This difference is unlikely to reflect a 
direct motor effect of the muscimol infusion, given that infusions were applied before the 
acquisition session, and cannot account for the reduced 2WAA learning in both TTX and 
muscimol groups. Finally, in Experiment 3, involving dorsal hippocampal infusions, the 
muscimol group showed more ITI crossing than the saline and TTX groups during blocks 2 to 
9 of acquisition (interaction group X blocks of 10 trials: F 18,369 = 2.05, P = 0.007), whereas 
the saline group showed more ITI crossing than the other two groups during blocks 1 to 3 of 
retention (interaction group X blocks of 10 trials: F 18,369 = 2.23, P = 0.003). Again, it is 
difficult to see how these differences could account for the impaired 2WAA learning in both 
the muscimol and TTX group. Moreover, analysis of escape failures did not reveal any 
significant group differences during acquisition or retention testing (all Fs < 2.59, Ps > 0.11) 
(Fig. 5 right). Overall, these data do not support that group differences in 2WAA learning 
were due to changes in motor activity (as reflected by ITI crossings) or by a failure to respond 
to the foot shock (as reflected by escape failure). 
         ___________________________ 
            Fig 5 insert about here 
          ___________________________ 
 
DISCUSSION 
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The main new finding of the present study is that temporary inhibition of hippocampal 
activity, using muscimol or TTX infusions into the dorsal or ventral hippocampus, disrupted 
2WAA learning. Muscimol or TTX infusions into the ventral hippocampus caused an 
immediate deficit in 2WAA performance, whereas following dorsal infusions rats performed 
similar to the control group for 40-50 min before a performance deficit emerged during the 
second half of the 2WAA acquisition session. In contrast to the impairments observed 
following temporary functional inhibition of the hippocampus by muscimol or TTX, 
NMDA-induced neurotoxic lesions to the complete hippocampus tended to facilitate, while 
neuronal lesions restricted to the dorsal or ventral hippocampus did not affect 2WAA 
learning.  
 
Effects of permanent hippocampal lesions 
Many previous studies have reported enhanced 2WAA learning following non-fiber 
sparing hippocampal lesions or fornix transections (Gray and McNaughton, 1983; 
Guillazo-Blanch et al., 2002; O'Keefe and Nadel, 1978; Olton and Isaacson, 1968; Pouzet et 
al., 1999; Tonkiss and Galler, 1990; Weiner et al., 1998). In the present study, we found a 
similar, albeit weaker, effect following neurotoxic lesions to the complete hippocampus. This 
new finding supports that permanent damage to hippocampal neurons, rather than to fibers of 
passage, leads to the facilitation of 2WAA learning. One interpretation of improved 2WAA 
learning following hippocampal lesions is that some aspects of hippocampal processing 
hinder 2WAA learning. As outlined in the Introduction, hippocampus-dependent one-trial 
place or context fear conditioning, inhibiting escape responses to a part of the chamber where 
the rat received a foot-shock on the previous trial, might hinder 2WAA learning. In addition, 
upregulation of nucleus accumbens dopamine transmission as a consequence of permanent 
hippocampal lesions (Lipska et al., 1992; Mittleman et al., 1993; Wilkinson et al., 1993) may 
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contribute to the facilitation of 2WAA learning, given that meso-accumbens dopamine 
transmission plays an important facilitating role in 2WAA learning (Boschen et al., 2011; 
Darvas et al., 2011; Dombroski et al., 2013; Shumake et al., 2010; Wadenberg and Hicks, 
1999). The upregulation of dopamine transmission following hippocampal lesion may also 
cause locomotor hyperactivity, which is often observed in open-field testing of rats with 
hippocampal lesions (Bast and Feldon, 2003; Gray and McNaughton, 1983). However, in the 
present study, hippocampal lesions did not cause any clear effects on ITI crossings, a measure 
of motor activity during 2WAA testing. This argues against non-specific motor effects as an 
explanation for the improved 2WAA learning following hippocampal lesions, consistent with 
previous studies (Gray and McNaughton, 1983; Olton and Isaacson, 1968). Therefore, the 
tendency of cytotoxic lesions of the complete hippocampus to facilitate 2WAA conditioning 
may reflect the disruption of rapid place or context conditioning, the upregulation of 
accumbens dopamine transmission or a combination of these two mechanisms. 
 
Effects of hippocampal muscimol and TTX infusion: ventral, but not dorsal, 
hippocampus contributes to two-way active avoidance learning 
In contrast to permanent hippocampal lesions, temporary functional inhibition of the 
hippocampus, using muscimol or TTX infusions into the ventral or dorsal hippocampus, 
markedly impaired 2WAA learning. The GABA-A agonist muscimol selectively inhibits the 
functions of neurons, whereas the sodium-channel blocker TTX also affects fibers of passage. 
In the present study, muscimol and TTX caused similar behavioral effects, suggesting that 
these effects mainly reflect the functional inhibition of hippocampal neurons, not inactivation 
of fibers of passage. Two-way active avoidance learning was markedly impaired throughout 
the complete acquisition session following ventral infusions, whereas following dorsal 
infusions an impairment only emerged during the second half of the acquisition session (i.e., 
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from 40-50 min after infusion). This suggests that functional inactivation of more ventral 
portions of the hippocampus, but not of the dorsal hippocampus, impairs 2WAA learning. The 
delayed impairment following dorsal drug infusions may reflect the time required for drug 
spread from the dorsal infusion site to more ventral parts of the hippocampus. Recent 
experiments combining muscimol infusion (0.5 ug/1 ul) with neuronal recordings in the 
dorsal hippocampus suggest that the extent of muscimol-induced functional inhibition of 
hippocampal neurons can spread by 0.5 mm in the horizontal direction within the first 6 min 
after infusion (Barry et al., 2012). Muscimol concentrations will fall below an effective 
concentration at further distance from the infusion site and it is difficult to accurately estimate 
the functional spread of the muscimol infusion (1 ug/0.5 ul) in our study. Nevertheless, it is 
plausible that during the first half (i.e., 40-50 min) of the acquisition session functional 
inhibition by muscimol might have spread from the dorsal infusion site to at least intermediate 
regions of the hippocampus, which are about 1-2 mm away from the dorsal infusion site. 
Drug spread outside of the hippocampus is unlikely given that the dense fiber bundles 
surrounding the hippocampal surface may largely prevent extra-hippocampal drug spread 
(Morris et al., 1989). In any event, our finding that muscimol and TTX infusions into the 
ventral hippocampus impaired 2WAA learning from the onset of the acquisition session 
(when neural effects of the drugs would have been restricted to the vicinity of the infusion 
site), whereas following dorsal infusions an impairment did not emerge before 40-50 min into 
the session, suggest that activity of more ventral regions of the hippocampus, but not the 
dorsal hippocampus, is required for 2WAA learning. Interestingly, in line with a preferential 
involvement of the ventral hippocampus in 2WAA learning suggested by our findings, a 
previous study showed that electrical kindling of the ventral, but not dorsal, hippocampus 
impaired 2WAA learning (Becker et al., 1997). 
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Contributions of the ventral hippocampus to two-way active avoidance learning 
Why does functional inhibition of ventral to intermediate regions of the hippocampus 
impair 2WAA learning? Even though ventral hippocampal muscimol and TTX infusions 
reduce open field locomotor activity (Bast et al., 2001b), our analysis of ITI crossings 
indicated that non-specific changes in motor activity could not account for the impairment of 
2WAA learning following these manipulations. Instead, functional inhibition of the ventral 
hippocampus may disrupt specific neural processes underpinning 2WAA learning. First, 
ventral hippocampal activity has been implicated in elemental classical fear conditioning, i.e. 
the formation of associations between an elemental CS, such as a tone, and an aversive US, 
such as a footshock (Bannerman et al., 2004; Fanselow and Dong, 2010). In fact, in our 
previous studies, we found that ventral hippocampal TTX infusion impaired the formation of 
elemental fear conditioning, even though ventral hippocampal muscimol (similar to dorsal 
hippocampal muscimol) only impaired contextual fear conditioning (i.e., formation of an 
association between a context and a footshock) (Bast et al., 2001b; Zhang et al., 2014)). The 
two-process view of 2WAA suggests that the acquisition of fear to the CS is necessary for 
learning 2WAA, because the fear to the CS is necessary to motivate the avoidance response 
(Choi et al., 2010). According to this view, ventral hippocampal processing may contribute to 
2WAA learning by supporting classical fear conditioning. In line with this suggestion, the 
lateral and basal nuclei of the amygdala, which are necessary for classical fear conditioning, 
are also required for 2WAA conditioning (Choi et al., 2010). These nuclei also feature strong 
anatomical links to the ventral hippocampus (Pitkanen et al., 2000). Second, the ventral to 
intermediate hippocampus exerts a positive control over the dopamine projections from the 
ventral tegmental area to the forebrain, including to the nuceus accumbens (Bast, 2007; Bast, 
2011; Grace et al., 2007; Taepavarapruk et al., 2008). It has also been directly demonstrated 
that TTX infusion into the ventral subiculum prevents activation of nucleus accumbens 
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dopamine transmission by novelty (Legault and Wise, 2001). There is strong evidence that 
activation of the meso-accumbens dopamine system supports 2WAA learning (Smith et al., 
2007; Boschen et al., 2011; Darvas et al., 2011; Dombroski et al., 2013; Ilango et al., 2012; 
Wadenberg and Hicks, 1999). Therefore, ventral hippocampal activity may also support 
2WAA learning by contributing to the activation of meso-accumbal dopamine transmission. 
 
Why may permanent lesions fail to reveal the contributions of the ventral hippocampus 
to two way active avoidance learning?  
One important consideration is that the ventral hippocampus may not make unique 
contributions to 2WAA learning. That is to say, the ventral hippocampal contributions to 
elemental classical fear conditioning and to the activation of the meso-accumbens dopamine 
system overlap with the contributions of other brain regions. For example, the lateral and 
basal nuclei of the amygdala are also important (and probably more important than the ventral 
hippocampus) for the association of an elemental CS and an aversive US (Fanselow and 
LeDoux, 1999.; Maren and Quirk, 2004) and several regions, including the basal and lateral 
amygdala and the prefrontal cortex, can activate the meso-accumbens dopamine pathway 
(Sesack and Grace, 2010). Therefore, the loss of hippocampal contributions may be 
compensated for by the contributions of other brain regions. Such compensation may 
particularly be possible following a complete and permanent loss of hippocampal activity, as 
resulting from permanent lesions. In contrast, residual, but severely disrupted, hippocampal 
activity, as can be expected following TTX or muscimol infusions, may less allow for 
compensation by other brain regions, because of residual, albeit faulty, hippocampal output 
(also compare Lomber, 1999). In addition, as already discussed above, permanent 
hippocampal lesions have been demonstrated to lead to an upregulation of accumbal 
dopamine transmission (Lipska et al., 1992; Mittleman et al., 1993; Wilkinson et al., 1993), a 
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secondary lesion effect that may even overcompensate for the loss of positive modulation of 
dopamine transmission by the ventral to intermediate hippocampus. 
 
Conclusions 
Using temporary functional inhibition by muscimol or TTX, the present study reveals 
that the ventral hippocampus contributes to 2WAA learning. These contributions may reflect 
the participation of the ventral hippocampus (1) in classical elemental fear conditioning and (2) 
in the activation of the meso-accumbens dopamine system, both of which processes that have 
been strongly implicated in 2WAA learning. The contributions of the ventral hippocampus to 
these two processes are not unique, but overlap with those by other brain regions. Two main 
reasons may explain why hippocampal lesions do not reveal these contributions. First, if 
hippocampal activity is permanently and completely lost, other brain regions may compensate 
for the loss of hippocampal function in 2WAA learning, whereas the temporarily limited and 
incomplete reduction of hippocampal function resulting from TTX and muscimol infusion 
may not equally allow for such compensation. Second, permanent hippocampal lesions cause 
an upregulation of meso-accumbens dopamine transmission, which may facilitate 2WAA 
learning.  
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Figure legends 
 
Fig. 1 Hippocampal lesions (Experiment 1) and infusions sites (Experiment 2 and 3). (A) 
Experiment 1: Photomicrographs of coronal sections showing a dorsal hippocampal (DH), 
ventral hippocampal (VH)  and complete hippocampal (CH)excitotoxic lesion (top) and 
schematic reconstruction of the smallest (solid black areas) and the largest (solid grey areas) 
extents of damage to the hippocampal region and the overlying cortex (bottom). (B) Infusion 
sites in the ventral (Experiment 2, n=17, left) and dorsal (Experiment 3, n=44, right) 
hippocampus: photomicrographs of a coronal brain section with the tracks of the guide 
cannula and the infusion sites visible in both hemispheres (top) and a schematic 
reconstruction of infusion sites on coronal sections. Coronal sections are adapted from the 
atlas of Paxinos and Watson (1998) and numbers indicate the distance from bregma.  
 
Fig. 2 Experiment 1: Effects of ventral, dorsal and complete hippocampal excitotoxic lesion 
on two way active avoidance performance. Percent avoidance responses (A) and 
avoidance/escape latencies (B) during acquisition and retention (two days apart).  Ventral 
hippocampal (VH), dorsal hippocampal (DH) or complete hippocampal (CH) lesions had 
been performed before acquisition. The control (Cont) group included sham-lesioned and 
unoperated rats. Avoidance response and latency data are expressed as the averages of 10 trial 
blocks. Values are means, error bars represent 1 standard error (S.E.) derived from ANOVA.  
 
Fig. 3 Experiment 2: Effects of tetrodotoxin or muscimol infusion into the ventral 
hippocampus on two way active avoidance performance. Percent avoidance responses (A) and 
avoidance/escape latencies (B) during acquisition and retention (two days apart). Rats were 
bilaterally infused with saline (0.5µl per side), muscimol (MUS, 1 µg/0.5µl per side), or 
Page 30 of 44
John Wiley & Sons
Hippocampus
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 31
tetrodotoxin (TTX, 10 ng/0.5µl per side) into the ventral hippocampus 20 min (TTX group, 
half of the saline group) or immediately (muscimol group, half of the saline group) before 
acquisition. All groups were tested again in the absence of infusion (retention) two days after 
the infusion day. Avoidance response and latency data are expressed as the averages of 10 
trial blocks. Values are means, error bars represent 1 standard error (S.E.) derived from 
ANOVA.  
 
Fig. 4 Experiment 3: Effects of tetrodotoxin or muscimol infusion into the dorsal hippocampus 
on two way active avoidance performance. Percent avoidance responses (A) and 
avoidance/escape latencies (B) during acquisition and retention (two days apart). Rats were 
bilaterally infused with saline (0.5µl per side), muscimol (MUS, 1 µg/0.5µl per side), or 
tetrodotoxin (TTX, 10 ng/0.5µl per side) into the dorsal hippocampus 20 min (TTX group, 
half of the saline group) or immediately (muscimol group, half of the saline group) before 
acquisition. All groups were tested again in the absence of infusion (retention) two days after 
the infusion day. Avoidance response and latency data are expressed as the averages of 10 
trial blocks. Values are means, error bars represent 1 standard error (S.E.) derived from 
ANOVA. 
 
Fig. 5 Experiment 1 to 3: ITI crossings and escape failures. ITI crossings (left) and escape 
failures (right) during acquisition and retention in Experiment 1 (hippocampal lesions before 
acquisition: Cont, control group; VH, ventral hippocampal lesion; DH, dorsal hippocampal 
lesion; CH, complete hippocampal lesions), Experiment 2 (ventral hippocampal muscimol, 
MUS, or TTX infusion before acquisition) and Experiment 3 (dorsal hippocampal muscimol, 
MUS, or TTX infusion before acquisition). ITI crossing are presented as the averages of 10 
trial blocks, with values showing means and error bars representing 1 standard error (S.E.) 
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derived from ANOVA. Escape failures are presented as total number throughout the complete 
100 trial acquisition or retention sessions, with values showing mean ± SEM. 
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Table 1. 
 
Complete Hippocampal Lesions 
AP ML DV vol(ul) 
-2.2 ±1.2 -3.3 0.075 
-2.7 ±1.9 -3.3 0.075 
-3.0 ±1.4 -3.3 0.050 
-3.0 ±1.4 -2.6 0.050 
-3.0 ±3.0 -3.1 0.100 
-3.5 ±3.5 -3.1 0.075 
-4.3 ±2.8 -3.3 0.050 
-4.3 ±2.8 -2.3 0.050 
-4.3 ±4.2 -5.0 0.025 
-4.3 ±4.2 -4.0 0.050 
-4.3 ±4.2 -3.0 0.050 
-4.8 ±4.8 -6.0 0.075 
-4.8 ±4.8 -5.0 0.050 
-5.1 ±4.2 -7.5 0.100 
-5.1 ±4.2 -5.5 0.075 
-5.1 ±4.2 -4.5 0.050 
-5.4 ±5.0 -6.5 0.100 
-5.4 ±5.0 -5.5 0.075 
        
Dorsal Hippocampal Lesions 
AP ML DV vol(ul) 
-2.4 ±1.0 -3.3 0.075 
-2.8 ±1.8 -3.3 0.075 
-3.2 ±1.4 -3.3 0.050 
-3.2 ±1.4 -2.6 0.050 
-3.2 ±3.0 -3.1 0.100 
-3.6 ±3.5 -3.1 0.075 
-4.4 ±2.8 -3.3 0.050 
-4.4 ±2.8 -2.3 0.050 
-4.4 ±4.0 -3.3 0.050 
-4.4 ±4.0 -2.3 0.050 
-5.4 ±4.1 -3.5 0.250 
        
Ventral Hippocampal Lesions 
AP ML DV vol(ul) 
-4.4 ±4.0 -4.0 0.025 
-4.9 ±4.8 -6.2 0.075 
-4.9 ±4.8 -5.2 0.050 
-5.2 ±4.2 -7.5 0.100 
-5.2 ±4.2 -4.8 0.075 
-5.5 ±5.0 -6.0 0.100 
-5.5 ±5.0 -4.9 0.075 
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Table 1. Stereotaxic coordinates and injection volumes used for NMDA injections (10 
mg/ ml) to induce neurotoxic lesions to the complete, dorsal, or ventral hippocampus . 
Anterior-posterior (AP), medio-lateral (ML) and dorsoventral (DV) coordinates are in 
mm. AP and ML were measured with respect to bregma, and DV relative to dura.  
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A 
-3.30 mm
-2.56 mm
-2.12 mm
-3.80 mm
-4.30 mm
-4.80 mm
-5.30 mm
IG
cg
cc
df DHC
dh c
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DG
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